Opioid receptor
7 drugs CNS
3
approved indications
7
Approved Drugs
7
Companies
7
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (7 companies)
✓ All 7 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (7 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
ZMI PHARMA 1 drug
Viatris 1 drug
SCIENTURE 1 drug
By Therapeutic Area
Other 6 drugs
CNS 1 drugs
Drugs by Company PRO
ZMI PHARMA 1 drug
Viatris 1 drug
SCIENTURE 1 drug
ALKERMES INC 1 drug
Hikma 1 drug
AMPHASTAR PHARMS INC 1 drug
RISING 1 drug
By Therapeutic Area
Other 6 drugs
ZIMHI, NALOXONE HYDROCHLORIDE, REZENOPY, KLOXXADO +2 more
CNS 1 drugs
LYBALVI
Indications Treated
Opioid OverdoseRespiratory DepressionCentral Nervous System DepressionLabor PainSchizophreniaBipolar I DisorderManic Episode
All Drugs Targeting Opioid receptor
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| ZIMHI | ZMI PHARMA | 2021 | 3 | |
| NALOXONE HYDROCHLORIDE | Viatris | 1986 | 3 | |
| REZENOPY | SCIENTURE | 2024 | 3 | |
| LYBALVI | ALKERMES INC | 2021 | 3 | CNS |
| KLOXXADO | Hikma | 2021 | 3 | |
| REXTOVY | AMPHASTAR PHARMS INC | 2023 | 3 | |
| SUFENTA PRESERVATIVE FREE | RISING | 1984 | 1 |